Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Harshabad Singh, M.B.,B.S.

Concepts (149)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Harshabad Singh's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Harshabad Singh has written about over time.
fms-Like Tyrosine Kinase 3, 3 publications between 2010 and 2011, average publication date April 2011. Barrett Esophagus, 2 publications between 2021 and 2021, average publication date September 2021. Adenocarcinoma, 6 publications between 2016 and 2024, average publication date February 2022. Carcinoma, Pancreatic Ductal, 5 publications between 2021 and 2023, average publication date February 2023. Colorectal Neoplasms, 5 publications between 2021 and 2025, average publication date March 2023. Fluorouracil, 2 publications between 2021 and 2024, average publication date March 2023. Leucovorin, 2 publications between 2021 and 2024, average publication date March 2023. Pancreatic Neoplasms, 9 publications between 2021 and 2024, average publication date April 2023. Appendiceal Neoplasms, 1 publications between 2023 and 2023, average publication date May 2023. Antineoplastic Combined Chemotherapy Protocols, 7 publications between 2021 and 2025, average publication date October 2023. Stomach Neoplasms, 2 publications between 2023 and 2024, average publication date January 2024. Receptor, ErbB-2, 3 publications between 2024 and 2024, average publication date April 2024. Deoxycytidine, 2 publications between 2023 and 2024, average publication date May 2024.

To see the data from this visualization as text, click here.
Singh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (149)
Explore
_
Co-Authors (106)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.